Presentation NY Valves 2024 Health Related Quality of Life and Functional Status Outcomes Comparing Transcatheter and Surgical Aortic Valve Replacement in Low-Intermediate Risk Patients for Surgery: A Metanalysis of Randomized Control Trials Presenter: Errol Christopher Moras June 06, 2024
Presentation NY Valves 2024 Frame Fibrosis of Transcatheter Heart Valves: A Potential Substrate for Impaired Neosinus Flow and Coronary Access? Presenter: Hacina Gill June 06, 2024
Presentation NY Valves 2024 Surgery Following Transcatheter Mitral Procedures: Outcomes and Perspectives Presenter: Vinay Badhwar June 06, 2024
Presentation NY Valves 2024 Will New VHD Screening Methods Address or Exacerbate Healthcare Disparities? Presenter: Suzanne J. Baron June 06, 2024
Presentation NY Valves 2024 Determinants of Intervention Type and All-Cause Mortality of TAVR and SAVR Patients Younger Than 75 Years in the Netherlands Presenter: Nicolas M. Van Mieghem June 06, 2024
Presentation NY Valves 2024 Asymmetric Expansion of Balloon Expandable Transcatheter Aortic Valve Prostheses: Implications for Valve Hemodynamics and Clinical Outcomes Presenter: Annette Maznyczka June 06, 2024
Presentation NY Valves 2024 TMVR Following Failed M-TEER: Technical and Procedural Considerations Presenter: Rodrigo D. Estevez-Loureiro June 06, 2024
Presentation NY Valves 2024 Designing Trials to Assess the Effectiveness of New VHD Screening Strategies Presenter: Timothy Joseph Poterucha June 06, 2024
Presentation NY Valves 2024 Gradients After Transcatheter Aortic Valve Replacements Are Impacted by Both Body Mass Index and Valve Size Presenter: Akhil Reddy June 06, 2024
Presentation NY Valves 2024 Bioprosthetic Valve Fracture for Mitral ViV Therapy: Indication, Technique and Outcomes Presenter: John Thomas Saxon June 06, 2024
Presentation NY Valves 2024 Echo-Derived Gradients Increase at 30 Days in Most Patients After Balloon-Expandable TAVR Irrespective of Valve Type and Valve Size Presenter: Spencer Ng June 06, 2024
Presentation NY Valves 2024 Screening for VHD: Beyond Proof of Concept to Implementation and Scaling Presenter: Sammy Elmariah June 06, 2024
Presentation NY Valves 2024 Pre-Emptive vs. Rescue LAMPOON in Mitral ViV and ViR Intervention: Indications and Technical Considerations Presenter: Jaffar M. Khan June 06, 2024
Presentation NY Valves 2024 Female Sex Is Not Associated With Increased Vascular Afterload in Older Patients With Aortic Stenosis Presenter: Sara Hungerford June 06, 2024
Presentation NY Valves 2024 The Landscape of Novel Methods to Screen for VHD Presenter: Sreekanth Vemulapalli June 06, 2024
Presentation NY Valves 2024 Procedural Planning in Mitral Valve Re-Intervention: Size and Shape of Neo-LVOT Matters! Presenter: Omar K. Khalique June 06, 2024
Presentation NY Valves 2024 Invasive Versus Echocardiographic Transvalvular Pressure Gradients After Transcatheter Aortic Valve Implantation Presenter: Eishan Ashwat June 06, 2024
Presentation NY Valves 2024 Invasive Exercise Hemodynamics in Aortic Stenosis Presenter: Abdullah Al-Abcha June 06, 2024
Presentation NY Valves 2024 The Importance of Patient Reported Outcomes in VHD Presenter: Suzanne V. Arnold June 06, 2024
Presentation NY Valves 2024 Diversity and Under Represented Populations in VHD: Focusing on Real Solutions Presenter: Annetine C. Gelijns, Megan Coylewright June 06, 2024